GT-100 SARS-CoV-2 Neutralizing Antibody Kit uses advanced immunofluorescence-based lateral flow technology for detection of neutralizing antibodies (NAb) to SARS-CoV-2 in human whole blood, serum and plasma. The GT-100 SARS-CoV-2 Neutralizing Antibody Kit, with the GT-100 Fluorescence Immunoassay Analyzer(FIA), provides automated and objective results in 12 minutes, allowing for monitoring immunity response after the second dose of the COVID-19 vaccine in point-of-care testing(POCT) scenarios.
Multiple clinical applications
Measuring the neutralizing antibodies potency are expected to build a defense against SARS-CoV-2 spreading, complementing vaccines and nonpharmaceutical interventions.
For vaccine efficacy monitoring
Understanding the human body’s immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
For treatment options guiding
Potent nAbs that were more effective at neutralizing the virus have better clinical outcomes. Early administration of nAbs is vital to identify patient of severity risk as an aid to treatment.
Features
Cost-effective, reproducible and time-saving
Only 12 mins for results.Suitable for large scale testing in point-of-care (POCT) way.
Quantitative and Accurate results
Up to 100% positive agreement with gold standard VNT method.
Easy to use
Simple test workflow, labor saving.
Advanced Fluorescence Immunoassay Technology
Objective result that eliminates the subjectivity of a visual read.
Cat.
GT12403
Description
GT-100 SARS-CoV-2 Neutralizing Antibody(NAb) Kit
Package size
25T/Box
Sample Type
whole blood, plasma, serum
GT-100 SARS-CoV-2 IgM/IgG Antibody(Ab) Kit
Cat.
GT12401
Description
GT-100 SARS-CoV-2 IgM/IgG Antibody(Ab) Kit
Package size
25T/Box
Sample Type
whole blood, plasma, serum
GT-100 SARS-CoV-2 Antigen(Ag) Kit
Cat.
GT12401
Description
GT-100 SARS-CoV-2 Antigen(Ag) Kit
Package size
25T/Box
Sample Type
Nasal swab
GT-100, One for All.
GT-100 SARS-CoV-2 Neutralizing Antibody(NAb) Kit
Monitoring COVID-19 vaccine efficiency.
GT-100 SARS-CoV-2 Neutralizing Antibody Kit uses advanced immunofluorescence-based lateral flow technology for detection of neutralizing antibodies (NAb) to SARS-CoV-2 in human whole blood, serum and plasma. The GT-100 SARS-CoV-2 Neutralizing Antibody Kit, with the GT-100 Fluorescence Immunoassay Analyzer(FIA), provides automated and objective results in 12 minutes, allowing for monitoring immunity response after the second dose of the COVID-19 vaccine in point-of-care testing(POCT) scenarios.
Multiple clinical applications
Measuring the neutralizing antibodies potency are expected to build a defense against SARS-CoV-2 spreading, complementing vaccines and nonpharmaceutical interventions.
For vaccine efficacy monitoring
Understanding the human body’s immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
For treatment options guiding
Potent nAbs that were more effective at neutralizing the virus have better clinical outcomes. Early administration of nAbs is vital to identify patient of severity risk as an aid to treatment.
Features
Cost-effective, reproducible and time-saving
Only 12 mins for results.Suitable for large scale testing in point-of-care (POCT) way.
Quantitative and Accurate results
Up to 100% positive agreement with gold standard VNT method.
Easy to use
Simple test workflow, labor saving.
Advanced Fluorescence Immunoassay Technology
Objective result that eliminates the subjectivity of a visual read.
Cat.
GT12403
Description
GT-100 SARS-CoV-2 Neutralizing Antibody(NAb) Kit
Package size
25T/Box
Sample Type
whole blood, plasma, serum
GT-100 SARS-CoV-2 IgM/IgG Antibody(Ab) Kit
Cat.
GT12401
Description
GT-100 SARS-CoV-2 IgM/IgG Antibody(Ab) Kit
Package size
25T/Box
Sample Type
whole blood, plasma, serum
GT-100 SARS-CoV-2 Antigen(Ag) Kit
Cat.
GT12401
Description
GT-100 SARS-CoV-2 Antigen(Ag) Kit
Package size
25T/Box
Sample Type
Nasal swab
POCT FIA (Fluorescence Immunoassay Analyzer) for COVID-19 Ag, Ab, NAb
TIME-RESOLVED FLUORESCENCE IMMUNOASSAY
GT-100 adopts time-resolved fuorescence immunoassay technology and uses europium, a rare lanthanide element, with long fuorescence lifetime and wide detection window
Excitation wavelength 340nm, emission wavelength 613nm, narrow emission peak, wide Stokes shift (wavelength difference between emission and excitation spectrum)
Easy to distinguish non-specific (background) fluorescence interference between excitation spectrum and emission spectrum, and fast disappearance of background fluorescence.
Dissociation enhancement technology can improve the fuorescence signal by 1 million times, and the detection accuracy can reach 10 mol/L.
Slim cartridge with minimized sample volume
Principle of time-resolved fuorescence immunochromatography
Principle of time-resolved fluorescence technique
FEATURES
Time-resolved fluorescence immunoassay, high precision, low interference;
Insert card to import calibration curve and reagent information,
One-step operation, 20 seconds to issue the test report;
Whole blood can be added directly to the test, no manual dilution;
Test results are automatically uploaded to LIS system, bitin printer
Microvolume blood needed as low as 2μL;
Support for venous / peripheral whole blood, serum, plasma samples;
FLEXIBLE APPLICATION SCENARIOS
EASY TO OPERATE
Two reagent cartridge types for quick and easy operation
Cassette type
Strip type
TEST MENU
Assay
Cartridge Type
Clinical significance
SARS-CoV-2 Antigen(Ag)
Strip
Rapid screening of suspected COVID-19 cases
SARS-CoV-2 Neutralizing Antibody(NAb)
Strip
Monitoring COVID-19 vaccine efficacy
SARS-CoV-2 IgM/IgG Antibody(Ab)
Strip
Aid testing for RT-PCR
negative or suspected
cases
CRP+SAA
Cassette
Infection diagnosis and differentiation of infection types
cTnl
Strip
Myocardial injury
markers
NT-proBNP
Strip
Heart Failure Markers
cTnI+NT-proBNP
Cassette
Myocardial injury, heart failure
POCT FIA (Fluorescence Immunoassay Analyzer) for COVID-19 Ag, Ab, NAb
TIME-RESOLVED FLUORESCENCE IMMUNOASSAY
GT-100 adopts time-resolved fuorescence immunoassay technology and uses europium, a rare lanthanide element, with long fuorescence lifetime and wide detection window
Excitation wavelength 340nm, emission wavelength 613nm, narrow emission peak, wide Stokes shift (wavelength difference between emission and excitation spectrum)
Easy to distinguish non-specific (background) fluorescence interference between excitation spectrum and emission spectrum, and fast disappearance of background fluorescence.
Dissociation enhancement technology can improve the fuorescence signal by 1 million times, and the detection accuracy can reach 10 mol/L.
Slim cartridge with minimized sample volume
Principle of time-resolved fuorescence immunochromatography
Principle of time-resolved fluorescence technique
FEATURES
Time-resolved fluorescence immunoassay, high precision, low interference;
Insert card to import calibration curve and reagent information,
One-step operation, 20 seconds to issue the test report;
Whole blood can be added directly to the test, no manual dilution;
Test results are automatically uploaded to LIS system, bitin printer
Microvolume blood needed as low as 2μL;
Support for venous / peripheral whole blood, serum, plasma samples;
FLEXIBLE APPLICATION SCENARIOS
EASY TO OPERATE
Two reagent cartridge types for quick and easy operation
Cassette type
Strip type
TEST MENU
Assay
Cartridge Type
Clinical significance
SARS-CoV-2 Antigen(Ag)
Strip
Rapid screening of suspected COVID-19 cases
SARS-CoV-2 Neutralizing Antibody(NAb)
Strip
Monitoring COVID-19 vaccine efficacy
SARS-CoV-2 IgM/IgG Antibody(Ab)
Strip
Aid testing for RT-PCR
negative or suspected
cases
CRP+SAA
Cassette
Infection diagnosis and differentiation of infection types
cTnl
Strip
Myocardial injury
markers
NT-proBNP
Strip
Heart Failure Markers
cTnI+NT-proBNP
Cassette
Myocardial injury, heart failure
*Product images are for illustrative purposes only and may differ from the actual product. Goldsite Diagnostics Inc. reserves the right to change the packaging design at anytime.
